LGND Ligand Pharmaceuticals
- 73.220
- +0.390+0.54%
- 73.220
- 0.0000.00%
Ligand Pharmaceuticals News
8-K: Ligand Reports First Quarter 2024 Financial Results
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
4: Statement of changes in beneficial ownership of securities-Director KOZARICH JOHN W
DEFA14A: Others
ARS: Annual Report to Security Holders
DEF 14A: Definitive information statements
8-K: Current report
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sabba Stephen L
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Ligand Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Ligand Pharmaceuticals | 10-K: Annual report
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Ligand Pharmaceuticals | 144/A: Others
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
